TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

Zhan Yao(Loxo Oncology at Lilly (United States)), Raffaella Sordella(Cold Spring Harbor Laboratory)
Proceedings of the National Academy of Sciences
August 16, 2010
Cited by 385


Related Papers